Select area to zoom
Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '252.000.941

Profile

Edit
Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. The company is focused on discovering and developing medicines in the field of immunotherapy. Its clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases (e.g. rezpegaldesleukin and NKTR-0165, respectively) and cancer (e.g. NKTR-255).
URL https://www.nektar.com
Investor Relations URL https://ir.nektar.com/
HQ State/Province California
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Mar. 04, 2025 (est.)
Last Earnings Release Nov. 07, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Nektar Therapeutics is a pharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. The company is focused on discovering and developing medicines in the field of immunotherapy. Its clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases (e.g. rezpegaldesleukin and NKTR-0165, respectively) and cancer (e.g. NKTR-255).
URL https://www.nektar.com
Investor Relations URL https://ir.nektar.com/
HQ State/Province California
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Mar. 04, 2025 (est.)
Last Earnings Release Nov. 07, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows